Table 2 Organ involvement of primary problem.
CMV-positive patients (n = 85) | CMV-negative patients (n = 387) | p value | |
|---|---|---|---|
Interstitial lung disease, n (%) | 30 (35.3%) | 62 (16.0%) | < 0.0001 |
Nephritis, n (%) | 20 (23.5%) | 45 (11.6%) | 0.0005 |
Arthritis, n (%) | 16 (18.8%) | 187 (48.3%) | < 0.0001 |
Peripheral nerve disorders, n (%) | 10 (11.8%) | 22 (5.7%) | 0.0070 |
Rash, n (%) | 8 (9.4%) | 34 (8.8%) | 0.1013 |
Myositis, n (%) | 7 (8.2%) | 28 (7.2%) | 0.0965 |
Pancytopenia, n (%) | 6 (7.1%) | 16 (4.1%) | 0.0412 |
Fever, n (%) | 5 (5.9%) | 11 (2.8%) | 0.0272 |
Alveolar hemorrhage, n (%) | 5 (5.9%) | 3 (0.8%) | 0.0001 |
Peripheral circulatory disorders, n (%) | 4 (4.7%) | 6 (1.6%) | 0.0111 |
Pleuritis, n (%) | 3 (3.5%) | 22 (5.7%) | 0.0660 |
Sore throat, n (%) | 3 (3.5%) | 6 (1.6%) | 0.0380 |
Eosinophilia, n (%) | 3 (3.5%) | 6 (1.6%) | 0.0380 |
Pericarditis, n (%) | 3 (1.9%) | 6 (1.6%) | 0.0380 |
Pulmonary hypertension, n (%) | 3 (3.5%) | 1 (0.3%) | 0.0004 |
Optic neuritis, n (%) | 3 (3.5%) | 0 (0.0%) | < 0.0001 |
Lymphadenopathy, n (%) | 2 (2.4%) | 7 (1.8%) | 0.0959 |
Central nervous system lupus, n (%) | 2 (2.4%) | 4 (1.0%) | 0.0530 |
Meningitis, n (%) | 2 (2.4%) | 4 (1.0%) | 0.0530 |
Pneumocystis pneumounia, n (%) | 2 (2.4%) | 2 (0.5%) | 0.0158 |
Genital ulcer, n (%) | 2 (2.4%) | 1 (0.3%) | 0.0842 |
Gastrontestinal ulcer, n (%) | 2 (2.4%) | 1 (0.3%) | 0.0043 |
Peritonitis, n (%) | 2 (2.4%) | 1 (0.3%) | 0.0043 |
Myelitis, n (%) | 2 (2.4%) | 1 (0.3%) | 0.0043 |
Epicarditis, n (%) | 1 (1.2%) | 1 (0.3%) | 0.0398 |
Oral aphtha, n (%) | 1 (1.2%) | 7 (1.8%) | 0.0921 |
Enteritis, n (%) | 1 (1.2%) | 3 (0.8%) | 0.0944 |
